NFKB1 and myotonic dystrophy type 2: The activation of Gla proteins affected the NF-kB/Nrf2 pathway (nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB)/nuclear factor erythroid 2-related factor 2) and decreased the risk of vascular inflammation in DM2 patients [111,112].